Effectiveness of spinal cord stimulation in diabetic patients with chronic limb-threatening ischemia: small cohort study

BackgroundChronic limb-threatening ischemia (CLTI) is the most severe form of peripheral artery disease (PAD). Patients with diabetes mellitus (DM) have a faster progression of PAD and a fourfold increased risk of CLTI compared to patients without DM. Epidural spinal cord stimulation (SCS) has been...

Full description

Saved in:
Bibliographic Details
Main Authors: Anna E. Cyrek, Dietrich Koch, Arkadius Pacha, Sonia Radunz
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-12-01
Series:Frontiers in Surgery
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fsurg.2024.1451622/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846136369021190144
author Anna E. Cyrek
Dietrich Koch
Arkadius Pacha
Sonia Radunz
author_facet Anna E. Cyrek
Dietrich Koch
Arkadius Pacha
Sonia Radunz
author_sort Anna E. Cyrek
collection DOAJ
description BackgroundChronic limb-threatening ischemia (CLTI) is the most severe form of peripheral artery disease (PAD). Patients with diabetes mellitus (DM) have a faster progression of PAD and a fourfold increased risk of CLTI compared to patients without DM. Epidural spinal cord stimulation (SCS) has been used as a method to improve microcirculation, relieve ischemic pain and reduce the number of amputations in patients with PAD. This is a retrospective small cohort analysis of patients with diabetes and the long-term treatment effect of spinal cord stimulation.MethodsAs the main outcome of the study, we evaluated the survival and amputation of 13 diabetic patients with chronic lower-limb ischemia who were not eligible for surgical or interventional therapy. Secondary outcomes included ankle-brachial index (ABI), ischemic pain intensity, quality of life, use of analgesic medications and skin wound outcomes analyzed during long-term follow-up.ResultsBetween January 2010 and January 2017, 13 patients underwent SCS implantation in our vascular center. At 1-year follow-up, the limb salvage rate was 92.3% (12 of 13 patients), and limb ulcers healed in 75% of patients (6/8). No patient died during the one-year follow-up. A total of 4 of patients (31%) experienced major amputation during long-term follow-up, all of them were Fontaine stage IV. Pain intensity and quality of life improved significantly at 6-month follow-up (p < 0.05). ABI measurements were unaffected by SCS treatment. There were no complications related to the procedure or device.ConclusionsSCS is a promising treatment option for diabetic patients unsuitable for endovascular or surgical revascularization. The method improves limb survival in diabetic patients with critical limb ischemia, provides significant pain control, and improves patients' quality of life. However, more studies are needed to clarify the indications for SCS and clarify its effects on the vascular system.
format Article
id doaj-art-10513798cf494f23ac305aa2012d7b9d
institution Kabale University
issn 2296-875X
language English
publishDate 2024-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Surgery
spelling doaj-art-10513798cf494f23ac305aa2012d7b9d2024-12-09T06:28:36ZengFrontiers Media S.A.Frontiers in Surgery2296-875X2024-12-011110.3389/fsurg.2024.14516221451622Effectiveness of spinal cord stimulation in diabetic patients with chronic limb-threatening ischemia: small cohort studyAnna E. Cyrek0Dietrich Koch1Arkadius Pacha2Sonia Radunz3Department of General, Visceral, Vascular and Transplant Surgery, University Hospital Essen, University Duisburg-Essen, Essen, GermanyDepartment of General, Visceral, Vascular and Transplant Surgery, University Hospital Essen, University Duisburg-Essen, Essen, GermanyInstitute of Pharmacology and Toxicology, Ruhr-University Bochum, Bochum, GermanyDepartment of General, Visceral, Vascular and Transplant Surgery, University Hospital Essen, University Duisburg-Essen, Essen, GermanyBackgroundChronic limb-threatening ischemia (CLTI) is the most severe form of peripheral artery disease (PAD). Patients with diabetes mellitus (DM) have a faster progression of PAD and a fourfold increased risk of CLTI compared to patients without DM. Epidural spinal cord stimulation (SCS) has been used as a method to improve microcirculation, relieve ischemic pain and reduce the number of amputations in patients with PAD. This is a retrospective small cohort analysis of patients with diabetes and the long-term treatment effect of spinal cord stimulation.MethodsAs the main outcome of the study, we evaluated the survival and amputation of 13 diabetic patients with chronic lower-limb ischemia who were not eligible for surgical or interventional therapy. Secondary outcomes included ankle-brachial index (ABI), ischemic pain intensity, quality of life, use of analgesic medications and skin wound outcomes analyzed during long-term follow-up.ResultsBetween January 2010 and January 2017, 13 patients underwent SCS implantation in our vascular center. At 1-year follow-up, the limb salvage rate was 92.3% (12 of 13 patients), and limb ulcers healed in 75% of patients (6/8). No patient died during the one-year follow-up. A total of 4 of patients (31%) experienced major amputation during long-term follow-up, all of them were Fontaine stage IV. Pain intensity and quality of life improved significantly at 6-month follow-up (p < 0.05). ABI measurements were unaffected by SCS treatment. There were no complications related to the procedure or device.ConclusionsSCS is a promising treatment option for diabetic patients unsuitable for endovascular or surgical revascularization. The method improves limb survival in diabetic patients with critical limb ischemia, provides significant pain control, and improves patients' quality of life. However, more studies are needed to clarify the indications for SCS and clarify its effects on the vascular system.https://www.frontiersin.org/articles/10.3389/fsurg.2024.1451622/fullcritical limb-threatening ischemiaperipheral arterial diseaseneuromodulationlong-term resultslimb salvagequality of life
spellingShingle Anna E. Cyrek
Dietrich Koch
Arkadius Pacha
Sonia Radunz
Effectiveness of spinal cord stimulation in diabetic patients with chronic limb-threatening ischemia: small cohort study
Frontiers in Surgery
critical limb-threatening ischemia
peripheral arterial disease
neuromodulation
long-term results
limb salvage
quality of life
title Effectiveness of spinal cord stimulation in diabetic patients with chronic limb-threatening ischemia: small cohort study
title_full Effectiveness of spinal cord stimulation in diabetic patients with chronic limb-threatening ischemia: small cohort study
title_fullStr Effectiveness of spinal cord stimulation in diabetic patients with chronic limb-threatening ischemia: small cohort study
title_full_unstemmed Effectiveness of spinal cord stimulation in diabetic patients with chronic limb-threatening ischemia: small cohort study
title_short Effectiveness of spinal cord stimulation in diabetic patients with chronic limb-threatening ischemia: small cohort study
title_sort effectiveness of spinal cord stimulation in diabetic patients with chronic limb threatening ischemia small cohort study
topic critical limb-threatening ischemia
peripheral arterial disease
neuromodulation
long-term results
limb salvage
quality of life
url https://www.frontiersin.org/articles/10.3389/fsurg.2024.1451622/full
work_keys_str_mv AT annaecyrek effectivenessofspinalcordstimulationindiabeticpatientswithchroniclimbthreateningischemiasmallcohortstudy
AT dietrichkoch effectivenessofspinalcordstimulationindiabeticpatientswithchroniclimbthreateningischemiasmallcohortstudy
AT arkadiuspacha effectivenessofspinalcordstimulationindiabeticpatientswithchroniclimbthreateningischemiasmallcohortstudy
AT soniaradunz effectivenessofspinalcordstimulationindiabeticpatientswithchroniclimbthreateningischemiasmallcohortstudy